Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing
P Del Gaudio, F De Cicco, RP Aquino, P Picerno… - Carbohydrate …, 2015 - Elsevier
Abstract In this paper, for the first time, hydrogels containing Annexin A1 N-terminal derived
peptide, Ac2-26, as a novel dressing were successfully developed for dermal wound repair
application. High mannuronic (M) content alginate and low molecular weight chitosan have
peptide, Ac2-26, as a novel dressing were successfully developed for dermal wound repair
application. High mannuronic (M) content alginate and low molecular weight chitosan have
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论